Skymab Biotherapeutics

Private

ToursHealthcare & Life Scienceshttps://skymab-biotherapeutics.com/

Last Round

Grant

Jun 2, 2026

Company Overview

Skymab Biotherapeutics is a drug discovery company that designs, engineers, and develops antibody-drug conjugates (ADCs) targeting G-protein-coupled receptors (GPCRs) for applications in oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCG-protein-coupled receptorsGPCRsGPCR targetingADC platformoncology therapeuticslinker technologycancer therapycleavable linkerpreclinical biotechdrug discoverybiopharma partnershipssolid tumorshematological malignancies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Skymab Biotherapeutics Comps

Public and private peers based on sector, stage, and business model.

Skymab Biotherapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Skymab Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jun 2, 2026
Grant	Feb 16, 2024
Grant	Jul 16, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Aiphi Nguyen

Co-founder and CEO

Founding Team

Skymab Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Skymab Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Skymab Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersTours

Employee Range13

Year Founded2019

Last FundingJun 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.